冠心病心绞痛的中医药干预模式综合疗效评价

发布时间：2018-08-17 09:02

【摘要】：目的:观察不同中医药干预模式治疗冠心病心绞痛的临床疗效。方法:将164例冠心病心绞痛气虚血瘀证和气滞血瘀证患者随机分为辨证论治组(82例)和辨病通治组(82例),在西医常规治疗基础上,辨证论治组采用病证结合、方证对应理论指导下的辨证论治干预模式,气虚血瘀证予芪参益气滴丸、气滞血瘀证予复方丹参滴丸;辨病通治组采用辨病论治干预模式,均予活血保心丸,疗程4周。分别从病、证、症层面进行疗效评价。结果:在硝酸甘油停减率方面两组效果相当。在中医证候积分方面辨证论治组优于辨病通治组(P0.05)。结论:辨证论治干预模式治疗冠心病心绞痛可发挥更好地疗效。
[Abstract]:Objective: to observe the clinical effect of different intervention modes of Chinese medicine on angina pectoris of coronary heart disease. Methods: 164 cases of angina pectoris with Qi deficiency and blood stasis syndrome and Qi stagnation and blood stasis syndrome were randomly divided into two groups: syndrome differentiation group (n = 82) and syndrome differentiation treatment group (n = 82). The intervention model of syndrome differentiation and treatment under the guidance of the corresponding theory of prescription syndrome, Qi deficiency and blood stasis syndrome were given Qishen Yiqi dripping pills, Qi stagnation and blood stasis syndrome were given compound Danshen dripping pills, and the disease differentiation and treatment group were treated with disease differentiation and treatment intervention model, all of them were given Huoxue Baoxin pills for 4 weeks. The curative effect was evaluated from disease, syndrome and symptom level respectively. Results: the two groups had the same effect in stopping and reducing rate of nitroglycerin. The syndrome differentiation and treatment group was superior to the syndrome differentiation and treatment group (P0.05) in the integral of TCM syndromes. Conclusion: the treatment of coronary heart disease angina pectoris with syndrome differentiation intervention mode can play a better effect.
【作者单位】：天津中医药大学第一附属医院;
【基金】：国家自然科学基金项目(No.30901890) 国家中医药管理局行业专项(No.201007003-03)~~
【分类号】：R259

【参考文献】